France's Sanofi Pharmaceutical Group is offering blackened antimalarial drugs to treat 300,000 people with MERS-CoV, AFP reported Wednesday. The Sanofi group announced that Blacknall, the antimalarial drug it produces, has demonstrated "promising" results in the treatment of patients with the new CORONA virus and is therefore ready to provide the French authorities with millions of doses of it, according to Sky News Arabic. "In light of the encouraging results of a study on this drug, Sanofi pledges to put its medicine within France's reach and provide millions of doses, a quantity that could allow the treatment of 300,000 patients," a spokesman for the group told AFP. To cooperate with the French authorities "to confirm these results". On Tuesday, more than 7,900 people worldwide died of MERS-CoV, while the number of infections approached nearly 200,000.
0 Commentaires